At what gestational age should a fetus with an isolated single umbilical artery and otherwise normal growth and reassuring antenatal testing be delivered?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: October 21, 2026 • View editorial policy

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.

Ask Question

Delivery Timing for Isolated Single Umbilical Artery

A fetus with an isolated single umbilical artery (SUA), normal growth, and reassuring antenatal testing should be delivered at 39-40 weeks of gestation, following routine obstetric management without early delivery.

Clinical Reasoning

The key distinction here is that your patient has an isolated SUA with normal growth and reassuring testing—this fundamentally changes the management approach compared to growth-restricted fetuses.

Why Not Earlier Delivery?

The SMFM guidelines 1 extensively address delivery timing for fetal growth restriction (FGR) with various Doppler abnormalities, but these recommendations apply specifically to growth-restricted fetuses, not to isolated SUA with normal growth. The guidelines recommend:

  • 38-39 weeks for FGR with estimated fetal weight between 3rd-10th percentile and normal umbilical artery Doppler 1
  • 37 weeks for FGR with decreased diastolic flow or severe FGR (<3rd percentile) 1

However, your fetus does not have FGR—it has normal growth.

Evidence-Based Management for Isolated SUA

The SMFM Consult Series #57 specifically addresses isolated SUA 2 and provides clear guidance:

  • No increased risk of aneuploidy with isolated SUA
  • Recommend third-trimester ultrasound to evaluate growth
  • Consider weekly antenatal surveillance beginning at 36 0/7 weeks
  • No recommendation for early delivery if growth remains normal

Supporting Research Evidence

Multiple studies demonstrate that isolated SUA with normal growth has favorable outcomes:

  • A 1995 study of 50 cases with isolated SUA showed mean gestational age at delivery of 38.6 weeks with no perinatal deaths and normal outcomes 3
  • A 2005 case-control study found no statistical difference in birth weight between isolated SUA and controls (3,268g vs 3,274g), with similar rates of SGA (7.1% vs 4.8%) 4
  • A 2024 study confirmed isolated SUA is not significantly associated with lower gestational age or increased complications when growth is normal 5

The Nuanced Risk Profile

While isolated SUA does carry some increased risks, these are primarily related to:

  • Small for gestational age (SGA): 2-3 fold increased risk 6, 7
  • Pregnancy-induced hypertension: Increased risk 6, 7
  • Stillbirth: Modestly increased risk 2, 7

However, these risks are mitigated by:

  1. Serial growth surveillance (third-trimester ultrasound)
  2. Antenatal testing starting at 36 weeks
  3. The fact that your fetus currently has normal growth and reassuring testing

Surveillance Strategy

For your patient with isolated SUA:

  • Perform third-trimester ultrasound (around 32-36 weeks) to confirm continued normal growth 2
  • Initiate weekly antenatal testing at 36 0/7 weeks (NST or biophysical profile) 2
  • Plan delivery at 39-40 weeks if growth remains normal and testing reassuring
  • Notify pediatric team at delivery about prenatal SUA diagnosis (7% may have structural anomalies detected postnatally) 2

Important Caveats

Do not wait beyond 40 weeks—while isolated SUA with normal growth doesn't require early delivery, the modest increase in stillbirth risk 2, 7 makes expectant management beyond term inadvisable.

Reassess if growth falters—if subsequent ultrasound shows FGR developing, then apply the FGR delivery timing guidelines (37-39 weeks depending on severity and Doppler findings) 1.

Monitor for hypertensive disorders—given the 3.5-fold increased risk of pregnancy-induced hypertension 6, maintain vigilance for signs of preeclampsia throughout the third trimester.

References

Related Questions

In a 22‑week pregnant patient with hypertension (blood pressure 145/89 mm Hg), does the presence of a single umbilical artery alter the indication or threshold for initiating antihypertensive therapy?
What is the clinical significance of a single umbilical artery (SUA) identified on obstetric ultrasound?
How should the CT findings of periventricular and subcortical gliosis, cerebral atrophy, and ventriculomegaly be interpreted in an 88-year-old patient after a fall?
What is the recommended pain management for acute herpes zoster?
What intramuscular dexamethasone dose should be used for vomiting when oral intake is impossible and intravenous access is unavailable?
Should I obtain an orbital CT scan for a patient involved in a motor‑vehicle collision with airbags deployment and vehicle rollover who now has eyelid bruising but no orbital tenderness?
In a patient with a documented codeine allergy and a patellar fracture, are morphine or hydromorphone (hydromorphine) contraindicated, and can ketorolac (Toradol) be used for pain control?
Can a cerebrospinal fluid (CSF) leak affect sexual orientation?

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.